Moreover, IDH-mutant gliomas harbor broad defects in DNA repair pathways, including homologous recombination and PARP-dependent base excision repair, due to oncometabolite-induced epigenetic dysregulation, potentially rendering them more sensitive to crosslinking agents like KL-5092–94. Here, IDH1 is linked to central nervous system cancer.